1. Clinical significance of serum triple monoclonal components: A report of 6 cases and a review of the literature
- Author
-
Umberto Falcone, Maria Giovanna Ferrara, Rita Rosaria Parascandola, Luciano Pezone, Antonello Sica, Anna Di Martino, and Salvatore Guastafierro
- Subjects
Male ,Immunofixation ,Cancer Research ,medicine.medical_specialty ,Pathology ,Lymphoproliferative disorders ,Disease ,Gastroenterology ,Polycythemia vera ,hemic and lymphatic diseases ,Internal medicine ,medicine ,Humans ,Clinical significance ,Polycythemia Vera ,Aged ,Aged, 80 and over ,biology ,business.industry ,Lymphoma, Non-Hodgkin ,Antibodies, Monoclonal ,Cancer ,Hematology ,medicine.disease ,Lymphoproliferative Disorders ,Lymphoma ,Oncology ,Monoclonal ,biology.protein ,Female ,Waldenstrom Macroglobulinemia ,business - Abstract
A serum multiple monoclonal component (MC) is very rare. We here report 6 patients with 3 MCs. The triple MC was detected in all of them by immunofixation. 2/6 patients did not present hematological or oncological associated disease, while in the remaining 4, Waldenstrom macroglobulinaemia (2 cases), Polycythemia Vera and non-Hodgkin lymphoma were diagnosed. Of the 49 global patients reported in the literature (6 + 43), 64.6% had a lymphoproliferative disorder and only in 3 cases there was no associated disease. Therefore, the detection of such laboratory evidence should propel physicians to a deeper investigation.
- Published
- 2014